Facebook
Twitter
LinkedIn
ForwardCardiovascular Conference: Precision Medicine in CV Disease—Where Are We and Where Are We Going?
While precision medicine as a healthcare strategy continues to evolve with early areas of impact on “the triple aim,” significant challenges stand in the way of its fully disruptive potential.
Please join Dr. Rhonda Cooper-DeHoff as she explores the current state of precision medicine, its growing ecosystem, and the opportunities that lie ahead for healthcare and research.
Locations
| Live- Baptist Hospital 5MCVI |
| Webcast |
Target Audience
Cardiologists, Interventional Cardiologists, Interventional Radiologists, General Internists, Primary Care Physicians, Intensivist, General Surgeons, Gynecologists, Anesthesiologists, Emergency Medicine Physicians, Hospitalists, Nurses and other interested healthcare providers.
Learning Objectives
- Understand the goals of precision medicine.
- Determine the significance of clinical implications of precision medicine.
- For a given patient, estimate therapeutic response to antiplatelet therapy using CYP2C19 genotype information.
- Apply lessons learned and consider future opportunities in the implementation of precision medicine.
Rhonda Cooper-DeHoff, Pharm.D., M.S., FAHA, FACC, FCCP
University of Florida
Associate Professor, University Term Professor
Director, Precision Medicine Program
Director, Graduate Program in Precision Medicine
Associate Director, Center for Pharmacogenomics and Precision Medicine
Department of Pharmacotherapy and Translational Research
Gainesville, Florida
Dr. Rhonda Cooper-DeHoff, indicated that neither she nor her spouse/partner has relevant financial relationships with commercial interest companies and she will not include off-label or unapproved product usage in her presentation or discussion.
Dr. Marcus St. John, conference director, is a member of the Speakers’ Bureau for Abiomed.
Other non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1 credit hour, CE Broker Course #20-103402, by the Florida Boards of Medicine and Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity has also been approved for 1 credit hour for Nurse Practitioners, Nurses, Pharmacists, Respiratory Therapists (personal growth), and Laboratory Personnel (molecular pathology) . Baptist Health South Florida CE Broker Provider #50-182.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Florida Board of Laboratory Personnel
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
- 1.00 Florida Board of Pharmacy
- 1.00 Florida Board of Respiratory Therapy
Pre-registration is required. Please log in to register.
Required Hardware/Software
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.